Cell surface transporters exploited for cancer drug delivery
Sunday, December 2, 2012 - 23:00
in Health & Medicine
A protein known as monocarboxylate transporter 1 (MCT1), which is highly expressed in a subset of metabolically altered cancer cells, is needed for the entry of the investigational cancer drug 3-bromopyruvate (3-BrPA) into malignant cells.